The Hindu Business Line : Matrix completes share purchase of DocPharma

MATRIX Laboratories Ltd has announced the completion of a share purchase of a controlling stake in the Belgium-based Docpharma NV from the Van Rompay family and other key shareholders.

The company announced the transaction on June 19.

In a press release here on Friday, Matrix Laboratories said it has purchased 13,70,085 shares (approximately 22 per cent of the issued share capital) in Docpharma NV at a price of 34 euros in cash for each share.

The share purchase was facilitated through the formation of a newly incorporated Belgian company, Matrix Laboratories NV, which is controlled by Matrix Laboratories.

Matrix said it would now launch a mandatory public takeover bid at the same price for the remaining shares.

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
USFDA inspects Lupin's Goa plant

SQL Star to issue shares, warrants on preferential basis

2 Indian cos raise $125 m in overseas markets

Apollo Hospitals GDR issue

Govt to expedite formation of co law tribunal

Independent directors: Survey finds most CEOs, MDs favour 25 pc limit

No Reliance de-merger proposal received yet, says Ministry

HED division transferred

Matrix completes share purchase of DocPharma

French company keen on acquiring stake in TELK

Asia MotorWorks plans to launch LCVs, MCVs

ONGC keen on coal bed methane projects — Shortlists 8 companies for final bidding

HPCL gearing up for financial closure of Guru Gobind refinery

Vivimed buys site for expansion

Labour trouble plagues auto cos in Gurgaon

Bharat Coking to float jt venture to develop virgin coal block

Sarvesh Refractory ties up with US co UCAR